The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.

Weaknesses in the oversight of the 340 drug-pricing program may allow some hospitals to get discounts they are ineligible for, a newly released report from the Government Accountability Office found.

WATKINSVILLE, GA / ACCESS Newswire / January 29, 2026 / In an era where staffing shortages, cost containment, and regulatory complexity challenge healthcare operations, pharmacy support offers ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Federal regulators have greenlit eight drugmaker ...

Six drugmakers who have violated the 340B statute should immediately begin offering drugs at discounted prices to hospitals participating in the federal drug-pricing program, according to a letter ...

HIV remains a persistent public health challenge in the United States. While infection rates have steadily declined over the past decade, access to proven prevention strategies—especially pre-exposure ...

The Trump administration's attempt to overhaul how safety net hospitals pay for outpatient drugs has run into a major legal wall, with a federal appeals court keeping a freeze on a controversial pilot ...

The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...